LFPI — LifePoint Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.00m
- -$0.02m
Annual income statement for LifePoint, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2000 March 31st | C2001 March 31st | C2002 March 31st | 2003 March 31st | 2004 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.136 | 0.049 | -0.019 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | -0.487 | -1.27 | -0.072 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.07 | 7.59 | 12.9 | 16.7 | 7.48 |
Operating Profit | -4.07 | -7.59 | -12.8 | -16.7 | -7.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.95 | -7.16 | -12.6 | -17 | -13.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.95 | -7.16 | -12.6 | -17 | -13.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.95 | -7.16 | -12.6 | -17 | -13.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.5 | -7.16 | -13.6 | -18.4 | -15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.295 | -0.235 | -0.428 | -0.487 | -0.36 |
Dividends per Share |